These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36263444)

  • 1. Mydriasis and anisocoria in a pediatric hyperhidrosis patient with interesting findings in the family cat.
    Sandhu M; Eisenstein K
    Pediatr Dermatol; 2023 Jan; 40(1):210-211. PubMed ID: 36263444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mydriasis secondary to use of glycopyrrolate cream.
    Radotra A; Baneke A; Paul B
    Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169
    [No Abstract]   [Full Text] [Related]  

  • 3. Dilated Pupil in a Patient With Hyperhidrosis.
    Micieli R; Micieli JA
    JAMA; 2019 Jul; 322(3):264-265. PubMed ID: 31219503
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis.
    Siscos SM; Figenshau K; Rajpara A
    J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717
    [No Abstract]   [Full Text] [Related]  

  • 5. Anisocoria secondary to antiperspirant wipes in a pediatric population: a case series.
    Pecha JD; Yen KG; Moisiuc A; Cantor A
    J AAPOS; 2022 Feb; 26(1):42-43. PubMed ID: 34798293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilated pupils caused by topical glycopyrrolate for hyperhidrosis.
    Panting KJ; Alkali AS; Newman WD; Sharpe GR
    Br J Dermatol; 2008 Jan; 158(1):187-8. PubMed ID: 17944977
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis.
    Green HH; Ray L; Buchanan J; Matsler N
    Am J Health Syst Pharm; 2023 Sep; 80(18):1234-1237. PubMed ID: 37348110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral mydriasis due to a topical "anti-sweat" preparation.
    Johnson C; Smereck J
    J Emerg Med; 2013 Mar; 44(3):673-4. PubMed ID: 23158696
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic anisocoria secondary to topical glycopyrronium for axillary hyperhidrosis: an emerging clinical presentation.
    Kaufman AR; Gulati S; Curnyn KM
    Can J Ophthalmol; 2020 Oct; 55(5):464. PubMed ID: 32735775
    [No Abstract]   [Full Text] [Related]  

  • 10. A 15-year-old girl with variable anisocoria.
    Coleman MJ; Tomsak RL
    Digit J Ophthalmol; 2014; 20(1):13-4. PubMed ID: 25097459
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible anisocoria due to inadvertent ocular exposure to topical anticholinergic treatment for primary axillary hyperhidrosis.
    Pashaei-Marandi A; Assam JH; Arnold A; Lee AG; Bonelli L
    Can J Ophthalmol; 2019 Dec; 54(6):e300-e302. PubMed ID: 31836120
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic Mydriasis Secondary to Topical Glycopyrronium Tosylate Cloths: Clinical Characterization From a Multicenter Analysis.
    Kaufman AR; Gulati S; Pula JH; Janetos TM; Cherayil NR; Chiu E; Shepherd EA; Golnik KC; Garcia-Valenzuela E; MacIntosh PW; Johnson BT; Curnyn KM
    J Neuroophthalmol; 2022 Dec; 42(4):530-534. PubMed ID: 35427257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
    Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
    Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mydriasis and accommodative failure from exposure to topical glycopyrrolate used in hyperhidrosis.
    Izadi S; Choudhary A; Newman W
    J Neuroophthalmol; 2006 Sep; 26(3):232-3. PubMed ID: 16966947
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
    Madan V; Beck MH
    Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
    Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmetic mydriasis.
    Köll B; Vynogradova I; Heckmann JG
    J Emerg Med; 2014 Jul; 47(1):84-5. PubMed ID: 24238593
    [No Abstract]   [Full Text] [Related]  

  • 20. A Case of Pharmacologic Anisocoria in Systemic Glycopyrrolate Use from Presumed Local Ocular Inoculation.
    Adamkiewicz D; Magazin M; Thomas D
    Neuroophthalmology; 2024; 48(1):41-45. PubMed ID: 38357624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.